The Immune Response to Glioblastoma: Overview and Focus on Checkpoint Blockade

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cancer immunotherapy has become a promising therapeutic modality in many tumor types. Recent evidence supports the idea that immune-based therapies may also be effective in treating central nervous system (CNS) malignancies. In order to design better immunotherapeutic approaches, however, it is first necessary to understand how the immune system interplays with cancer. Furthermore, with regard to CNS malignancies, a deeper understanding of how the immune system surveys the CNS adds an additional layer of complexity. This chapter will provide a basic overview of the immune system as a foundation to focus specifically on CNS immunosurveillance, particularly as it relates to detection of intracranial tumors. Lastly, we will review the current understanding of mechanisms employed by brain tumors to evade immune detection, with a focus on immune checkpoint pathways.

Original languageEnglish
Title of host publicationHandbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages653-668
Number of pages16
ISBN (Print)9780128121009
DOIs
StatePublished - Apr 24 2018

Keywords

  • Cancer immunity cycle
  • Checkpoint blockade
  • Glioblastoma
  • Tumor immunology

Fingerprint Dive into the research topics of 'The Immune Response to Glioblastoma: Overview and Focus on Checkpoint Blockade'. Together they form a unique fingerprint.

  • Cite this

    Johanns, T. M., & Dunn, G. P. (2018). The Immune Response to Glioblastoma: Overview and Focus on Checkpoint Blockade. In Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition (pp. 653-668). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-812100-9.00052-8